Using machine learning, an electronic nose can "smell" early signs of ovarian cancer in the blood. The method is precise and, ...

A blood sample does not have an obvious odor to a person in a lab coat. But to an electronic nose, it can carry a chemical signature that points toward disease.

Researchers have developed an electronic nose that can “smell” early signs of ovarian cancer in the blood. The method is precise and could eventually be used to find many different cancers.

Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...

A new study suggests that a machine designed to copy the human sense of smell could one day help doctors detect ovarian cancer much earlier than before. Researchers from Linköping University in Sweden ...

Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...

Khaberni - Early cancer detection technologies are undergoing a radical transformation with the emergence of multicancer blood tests (MCED), which rely on the analysis of free DNA ...

Pancreatic ductal adenocarcinoma is one of the most lethal cancers, in large part because it usually stays hidden until it has already spread. Survival curves change dramatically when tumors are ...

The researchers measured the variation in DNA methylation patterns to develop the method and applied it to multiple types of cancer.

Baseline LDH as a prognostic biomarker of early treatment failure in lung cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text ...